References



Accumol was founded in May 2010 and is a privately-owned biotechnology company based in Calgary. We are dedicated to providing clinical laboratories with innovative molecular biology reagents, tailored to their specific needs. These reagents are designed from the start to be easily implemented within existing workflows and procedures, and to leverage existing equipment and expertise. Accumol's Non-T and Non-B Genomic Detection Kits are designed to control purity of cells sorted for lineage-specific chimerism analysis.

Angio-Proteomie, a globle supplier of biomedical research reagents, is dedicated in serving the Biomedical Research Communities, with top quality primary endothelial cells.
Founded in 2006, Akron Biotech is a privately owned company headquartered in South Florida, U.S., with a strategic focus on supplying technology, tools, and services to the regenerative medicine industry. A global supplier, Akron manufactures and distributes components and raw materials for cell therapy discovery, development, and commercialization, meeting the industry’s needs worldwide. Our business model emphasizes flexibility, quality, and service. Akron works closely with its clients, from research and development through clinical trial, then on to market authorization and commercial product.
baseclick – get the click chemistry. Baseclick, founded 2008 and based in the Munich area, offers products based on the outstanding “click technology”. The detection of cell proliferation is of utmost importance for assessing cell health, determining genotoxicity or evaluating anticancer drugs. The core of the this technology is the “click reaction”, a copper catalyzed cycloaddition allowing virtually unlimited functionalization of both small synthetic oligonucleotides and large gene fragments with unprecedented efficiency. Characteristic therefore are the broad application possibilities, high yields and easy & quick reaction conditions using readily available and inexpensive reagents.
BioCision: To standardize pre-analytical sample handling. We develop and provide products that eliminate variability in common, often-overlooked, laboratory procedures.
BioLife Solutions, (NASDAQ: BLFS), is the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze. The Company’s proprietary HypoThermosol® and CryoStor® platform of solutions are highly valued in the biobanking, drug discovery, and regenerative medicine markets. BioLife’s biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death. BioLife’s enabling technology provides commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and function of cells, tissues, and organs.
BioConcept-AMIMIED is a manufacturer of classical Tissue Culture Media as well as of all kinds of customer designed Media. Our major focus is on Animal Component Free (ACF) media for research and production. The manufacturing part of the company is equipped with designated ACF vessels and manufac¬turing devices.
Bio-Nobile™ purification solutions based on magnetic particle technology. BN P&S manufactures and sells globally the Bio-Nobile brand manual and automated solutions for nucleic acid, cell and protein purification.
Cell Applications, Inc., your worldwide provider of primary cell culture systems. We offer a wide array of primary cell types, optimized growth media, supporting cell culture reagents & antibodies to serve your cell-based research & development goals.
Celenys offers hyaluronic acid scaffolds in a ready-to-use format for 3D cell culture.
Cell Biologics is a premier company and the first to offer genetically modified and normal mouse primary endothelial cells and other mouse cell types. The production of mouse primary endothelial cells was not economically or technically feasible until the creation of our company- Cell Biologics.
CelProgen is a biotechnology company developing stem cell research and therapeutics products for regenerative medicine in cardiology, oncology, diabetes & neurology. Celprogen offers customized and a large variety of stem cells, cancer stem cells, iPC's & media including ECM's, and provides novel molecular diagnostics and therapeutic product development solutions for Biotechnology, Pharmaceutical, Invitro diagnostics and academic partnership for drug discovery.
Cellworks is a division of Caltag Medsystems, and was created following the recent merger of TCS Cellworks and Caltag Medsystems. Cellworks provides Angiogenesis focused Cells, Kits and Reagents for Scientific Research.
Columbia Biosciences has expertise associated with culturing microalgae, harvesting their fluorophores and conjugating them to antibodies for sale as biologic reagents. Columbia has developed new fluorescent products including B-phycoerythrin (B-PE), R-phycoerythrin (R-PE), Peridinin chlorophyll (PerCP) and their associated tandem fluorophores. They have also licensed Dylight® fluorophores, which allows them to make high intensity conjugates for use in fluorescent microscopy and High Throughput Screening (HTS). Columbia Biosciences manufactures and sells donor and acceptor fluorophore conjugates. The company's product catalog includes a large variety of anti-epitope tag antibodies and streptavidin conjugates for TR-FRET (LANCE®, HTRF®). The conjugates labeled with SureLight® APC or Dylight® 650 can be paired Europium cryptate and chelate based donors. PE or Dylight® 550 conjugates can be paired with Terbium chelate based donors.
Cyagen is the world's leading research-use stem cell producer. Our stem cell products include embryonic stem cells and somatic stem cells derived from various species as well as their genetically modified derivatives.
Detroit R&D, Inc. was founded in 1997 by Dr. Hyesook Kim as a company dedicated to building a relationship of trust with the research community, by providing the highest quality products through leading-edge technology. Detroit R&D specializes in environmental health science, hypertension and breast and prostate cancers, including research on biologically active eicosanoids such as EET, DHET and 20-HETE, environmental estrogens such as BPA, prostaglandin H synthase (PGHS, also called COX), cytochromes P450 (CYPs), glutathione S-transferases (GSTs), oxidative stress, DNA damage, Xenopus, drug-metabolism, breast and prostate microarrays and wound healing.
GenXPro ist auf die Analyse der Nukleotid-basierten Informationen biologischer Proben aller Art spezialisiert. Die intelligente Kombination von Techniken zur Reduktion komplexer Daten mit den neuesten Hochdurchsatz-Sequenzier-Technologien ermöglicht es, ein Dienstleistungsportfolio mit höchst genauen und kosteneffizienten Lösungen für die Transkriptomik, Genomik und epigenetische Forschung anzubieten. Schwerpunkte sind Transkriptomik: deepSuperSAGE und MACE, Strangspezifische RNAseq etc. Genomik: SNPs, Indels, Polymorphismen für GWAS, hochdichte genetische Kartierung etc. Epigenomik: Genomweite Analyse der Methylierung von CpG-Inseln/-Promotoren, etc.
DV Biologics is a global supplier of human biological tools to academic institutions and pharmaceutical companies engaging in cell and drug based discovery and development. Our mission is to provide biological tools needed to advance the innovation of technology that will ultimately be used to treat or prevent multiple human degenerative disorders and diseases.
InSphero supplies organotypic 3D microtissue spheroids in a format ideally suited to drug testing. In addition, we can also equip and train customers to produce their own specialized scaffold-free 3D microtissue models using InSphero´s patent-pending microtissue technology.
Kaly-Cell is our partner for human hepatocytes fresh and cryopreserved. Kaly-Cell established a procedure to produce cryopreserved hepatocytes which are nearly as good as fresh ones.
Stemmatters is a biotechnological company focused on the development of novel products and services for tissue repair and regeneration. The organization is a spin-off company from the 3B'sesearch Group of the University of Minho, Portugal and it is located in the same building of the European Institute of Excellence for Tissue Engineering and Regenerative Medicine Research. Stemmatters has fully independent premises including R&D, QC laboratories and a GMP facility for the processing of cells and tissues. Irisbiosciences is a business division and a registered trademark of Stemmatters focused on development and marketing of B2B products and services for biomedical sciences (research use only). We address the needs of business organizations in the biomedical field, as well as of research driven organizations such as universities, research centres and any other institution performing R&D in life-sciences or related domains. This business unit provides CRO services in specialized early-stage development of advanced therapy medicinal products (ATMPs) and medical devices therapeutic development. Irisbiosciences manipulates cells and tissues taking into account requirements of the EU and Cells Directives (EUTCD) and (cGMP).
Metafora Biosystems developed cell metabolism assays using RGBs (Receptor Binding Domain). RGBs are ligands of nutrient transporters and are used to detect metabolic differences via transporter activity at the cell surface. Furthermore expression profiles for various transporters literally generate a signature, that reflects dysfunction, and adaptations of cell metabolism.
MicroStem, Inc. has developed a novel technology which thousands of extracellular proteins, growth factors and signaling molecules can be screened individually and in combination on a functionalized glass slide. Cell behavior on these conditions can be monitored and quantified. MicroStem will utilize this specialized cell array screening system to elucidate the physiologically relevant microenvironments that drives the EMT process for lung cancer cells. MicroStem's unique MicroMatrixTM array technology will serve as a novel platform to understand the interaction between tumor cells and their microenvironment (cell-cell, cell-matrix). The results of this study will advance the basic understanding of the natural process for tumor invasion and metastasis in lung cancer; and therefore, laying out a foundation to discover more effective therapeutic drugs.
Nano3D Biosciences (n3D) has developed magnetic cell culture systems to address the unmet need for 3D cell culture systems that are robust yet rapid and easy. Their technology centers around the use of NanoShuttleTM-PL, biocompatible magnetic nanoparticles, to magnetize cells so they can be easily manipulated with magnetic forces. Using this technology, users can levitate cells or rapidly print cells into tissue-like structures. The applications of this technology are wide-ranging, from biomedical research to compound screening to tissue engineering. n3D mission is to develop their magnetic cell culture technology into the industry standard for 3D cell culture.
Novoprotein is a contract research biotech company dedicated solely to recombinant protein service and product. Novoprotein possesses advanced technology and extensive experience in the field and offers a comprehensive service portfolio, from protein expression, antibody production, protein modification, and protein crystallization. Novoprotein offers more than 750 recombinant proteins off-the-shelf.
ReachBio provides specialized Contract Assay Services to a variety of life science organizations, from global biopharmaceutical companies to virtual biotech companies and start-ups. We offer a variety of standardized functional cell-based assays using normal or disease-specific primary cells (human and other species). Our standardized in vitro assays are ideal for evaluating drug toxicity, bone marrow modulation, biological mechanism and other questions.
Reinnervate has developed the AlvetexÒ platform for 3D Cell Culture.
ReproCELL Inc. was established in 2003 with the goal of contributing to people's health and welfare through the development of stem cell technologies. Many of ReproCELL's technologies were developed by stem cell pioneers, Prof. Norio Nakatsuji from the Institute for Frontier Medical Sciences, Kyoto University, and Prof. Hiromitsu Nakauchi from The Institute of Medical Sciences, The University of Tokyo.
ReSyn Biosciences is specialized in high-performance high capacity magnetic microsphere products, the MagReSyn® range. The South-African start-up was awarded with the New Product Award (NPA) at the Society for Lab Automation and Screening (SLAS) conference and exhibition 2015 in Washington DC, USA. The high-performance MagReSyn® products are suitable for a range of proteomics, molecular and cell biology applications. The products are HT compatible and suitable for automation of workflows. The ReSyn polymer technology has been derivatized into a range of magnetic microsphere products with high capacity and specificity, to meet the most stringent R&D requirements. We are continually developing innovative new products to provide enhanced solutions for every application.
SIRION BIOTEC is a technology leader in the field of functional gene analysis and sophisticated cell modeling for basic research, the drug, food and cosmetic industries. Combining its proprietary viral vector platform, RNAi technology and outstanding expertise in cells, SIRION BIOTECH enables much improved target research and compound screening.
Stemgent is our partner for iPS tools. Stemgent was founded in 2008 and is an expert in cellular reprogramming and offers a complete portfolio from cellular reprogramming to small molecules.
Founded in 2013, StemTek Therapeutics is a biotech startup entirely dedicated to cancer stem cell research (CSC) and drug discovery for novel anticancer therapies. Based in Bilbao, Spain, StemTek uses 3D cell based assay automated for HTS, allowing the company to test thousands of compounds that target cancer stem cells to stop spheroid formation. 3D cell culture systems allow for stronger, more efficient and reliable drug screening. StemTek collaborates with pharmaceutical and biotech companies to accelerate early stage drug screening to develop new anticancer therapies.
SynVivo has developed microfluidics-based chips. These cell based assays provide morphologically and biologically realistic microenviroments and allow real-time study of cellular behavior, drug delivery and drug discovery – fast and cost effective, for industry and pharma research. Basic applications are f.ex: Inflammation (leukocyte-endothelium), Cancer (tumor-endothelium), Thrombosis (platelet-endothelium) and Infection (microbial-endothelium). The SynVivo® microfluidic cell-based assay platform has been recognized as one of the “Top 10 Innovations” by The Scientist magazine.
VitaCyte LLC manufactures highly purified and rigorously characterized tissue dissociating enzymes, sold as individual enzyme products or as enzyme formulations for specific cell isolation applications. The enzyme formulations are designed to achieve high viable cell yield, very low contaminant levels, and lot-to-lot consistency.
Xellutec produces Xellulin Scaffolds for long term cell culture of primary cells.


Contact Us

phone +49(0)89517 771 40
fax +49(0)89 517 771 60
info@pelobiotech.com

Our Partners

cryo_shop Our partnership with CryoShop gives you the choice to work together with experts in cryopreservation and sample handling.